While the Tumor Immune Dysfunction and Exclusion (TIDE) did not show significant differences between risk groups, the expression of Microsatellite Instability (MSI), Merck18, CD8, Dysfunction, Exclusion, MDSC, and TAM M2 scores was notably lower in the high-risk group (Fig. 6C). This evidence concerns the gene CD8A and neoplasm.